glp-1 news today recency 3 GLP1 receptor agonists are widely used to treat type 2 diabetes and obesity, and a study by @ThisIsUIC researchers in the journal Endocrine-Related Cancer examines their role in #prostatecancer. The study's principal GLP-1 Pipeline Update: May 2025
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16



























